Andrew Welch, DO

Welch, Andrew A; Toro-Tobon, David; Rachmasari, Kharisa N; Sandooja, Rashi B; Rahimi, Leili; Mohan, Sneha; Hewlett, Jennifer R; Clark, Jennifer; Maheshwari, Arvind; Zhang, Catherine; Brito, Juan P 2024. Improving Intravenous and Subcutaneous Insulin Overlap During Treatment of Diabetic Ketoacidosis: A Quality Improvement Project. Mayo Clinic proceedings. Innovations, quality & outcomes, 8 3, 293-300

Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian 2023. The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes, 72 4, 449-454

Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian 2023. Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes. American journal of physiology. Endocrinology and metabolism, 325 2, E119-E131

Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian 2023. The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans. The Journal of clinical investigation, ,

Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh 2017. Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2). Diabetes, 66 8, 2201-2212